NCT07361926Not yet recruiting
Sexual Health Access at Retail Pharmacies: Advancing Pharmacy-based Delivery of Primary STI and HIV Prevention for Cisgender Women
Source: ClinicalTrials.gov · Last updated 28 Jan 2026
Brief summary (registry, in English)
This proposed 3-arm randomized study will compare different pharmacy based approaches that include HIV prevention medication (PrEP and PEP), routine STI testing, and preventive antibiotic (doxycycline) for STIs. The study will assess how well these services can be implemented, how acceptable they are to young women, and whether they are cost-effective.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 720 (estimated)
- First submitted
- 21 Jan 2026
- Start date
- May 2026
- Primary completion date
- Jun 2029
- Lead sponsor
- University of Washington
- Diseases
- HIV
- NCT number
- NCT07361926
What you commit to
- Study type: Interventional
- Planned participants: 720
- From May 2026 to the primary completion date, Jun 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Medical contraindications to PrEP or doxycycline use (e.g., severe allergy to doxycycline, serious hepatic or renal disease).
- Any other condition that, in the investigator's judgment, would make participation unsafe or interfere with study procedures.
Other
- Current participation in other ongoing studies.
Who the study is looking for
- Cis-gender female
- Seeking contraception (emergency contraception, oral contraceptive pills, injectables, implants, and condoms) from the retail pharmacy site
- Age ≥ 15 and \<25 years old
- Willingness to receive PrEP screening per national guidelines including HIV testing
- Not currently taking PrEP
- Planning to reside in the area for the next 12 months
- Able and willing to provide informed consent for participation
Age in the registry: 15 years to 24 years · Sex: Female · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.